Abstract: An ophthalmic device for slowing, inhibiting or preventing myopia progression which is a polymerization product of a monomeric mixture comprising (a) greater than 50 wt. %, based on the total weight of the monomeric mixture, of one or more non-silicone-containing hydrophilic monomers; (b) one or more crosslinking agents; and (c) one or more red-light blocking compounds blocking greater than 5% to about 25% of red-light transmission through the ophthalmic device at a wavelength of from about 550 nm to about 800 nm, wherein the one or more red-light blocking compounds have one or more ethylenically unsaturated reactive end groups.

Abstract: A grafted glycosaminoglycan polymer is disclosed. The grafted glycosaminoglycan polymer comprises a glycosaminoglycan having a polymer backbone and one or more side chains comprising a polyalkylene glycol-containing residue grafted onto the polymer backbone.

Abstract: A grafted glycosaminoglycan polymer is disclosed. The grafted glycosaminoglycan polymer comprises a glycosaminoglycan having a polymer backbone and one or more side chains comprising a polyalkylene glycol-containing residue grafted onto the polymer backbone.

Abstract: Systems and methods for removing a material from a lumen or duct include a guide wire to navigate to the material and a cutting assembly that can then be guided along the guide wire to reach the material. A proximal wire end can be connected to a pump device configured to provide an irrigation substance along a delivery channel of the guide wire and release the irrigation substance at a distal wire end. A power source can apply a current to the guide wire to magnetize a coupling assembly disposed on the guide wire. The cutting assembly can couple to the guide wire by engaging a locking mechanism of the cutting assembly with a coupling assembly of the guide wire.

Abstract: A biomedical device having a coating on a surface thereof, where the coating includes a glycophospholipid polymer which is a reaction product of one or more glycosaminoglycans and one or more phospholipids.

Abstract: A multifunctional crosslinking agent includes one or more repeating units of a siloxanyl group or a silyl-alkyl-siloxanyl group, and at least two ethylenically unsaturated reactive end groups. One of the at least two ethylenically unsaturated reactive end groups is a (meth)acrylate-containing reactive end group or an acrylamide-containing reactive end group and the other one is an allyl-containing reactive end group or a vinyl-containing reactive end group.

Abstract: Systems and methods for removing a material from a lumen or duct include a guide wire to navigate to the material and a cutting assembly that can then be guided along the guide wire to reach the material. A proximal wire end can be connected to a pump device configured to provide an irrigation substance along a delivery channel of the guide wire and release the irrigation substance at a distal wire end. A power source can apply a current to the guide wire to magnetize a coupling assembly disposed on the guide wire. The cutting assembly can couple to the guide wire by engaging a locking mechanism of the cutting assembly with a coupling assembly of the guide wire. The locking mechanism can receive torque provided by a motor coupled to the proximal wire end of the guide wire to rotate the cutting tool of the cutting assembly to remove the material.

Abstract: A glycophospholipid polymer is disclosed. The glycophospholipid polymer comprises a reaction product of one or more glycosaminoglycans and one or more phospholipids. Also disclosed is a glycophospholipid polymeric network comprising a reaction product of one or more glycosaminoglycans, one or more phospholipids and, one or more crosslinking agents.

Abstract: An ophthalmic device for slowing, inhibiting or preventing myopia progression which is a polymerization product of a monomeric mixture comprising (a) greater than 50 wt. %, based on the total weight of the monomeric mixture, of one or more non-silicone-containing hydrophilic monomers; (b) one or more crosslinking agents; and (c) one or more red-light blocking compounds blocking greater than 5% to about 25% of red-light transmission through the ophthalmic device at a wavelength of from about 550 nm to about 800 nm, wherein the one or more red-light blocking compounds have one or more ethylenically unsaturated reactive end groups.

Abstract: A biomedical device is disclosed. The biomedical device includes a polymerization product of a biomedical device-forming mixture containing (a) one or more grafted glycosaminoglycan polymers including a glycosaminoglycan having a polymer backbone and one or more side chains comprising an ethylenically unsaturated reactive-containing residue grafted onto the polymer backbone, and (b) one or more non-silicone biomedical device-forming monomers.

Abstract: A cassette with free flow prevention for use with an ambulatory pump. The cassette includes a free flow prevention clamp and a housing. The free flow prevention clamp includes a clamping section having a first side and a second side, a first elongate section extending from the first side, and a second elongate section extending from the second side. The housing supports the free flow prevention clamp and defines a channel for receiving a tube. The elongate sections extend parallel to the channel and the clamping section extends across the channel. The free flow prevention clamp is configurable within the housing in an open condition that allows fluid flow through the tube when force is applied to one of the elongate sections and in a closed condition that prevents fluid flow through the tube when the force is removed from the elongate sections.

Abstract: Systems and methods for removing a material from a lumen or duct include a guide wire to navigate to the material and a cutting assembly that can then be guided along the guide wire to reach the material. A proximal wire end can be connected to a pump device configured to provide an irrigation substance along a delivery channel of the guide wire and release the irrigation substance at a distal wire end. A power source can apply a current to the guide wire to magnetize a coupling assembly disposed on the guide wire. The cutting assembly can couple to the guide wire by engaging a locking mechanism of the cutting assembly with a coupling assembly of the guide wire. The locking mechanism can receive torque provided by a motor coupled to the proximal wire end of the guide wire to rotate the cutting tool of the cutting assembly to remove the material.

Abstract: A method for preparing an ophthalmic device containing an ultraviolet (UV) blocker is disclosed. The method involves (a) soaking an ophthalmic device in one or more first solvent solutions to swell the ophthalmic device; (b) soaking the swelled ophthalmic device in one or more second solvents solutions comprising a UV blocker to de-swell the ophthalmic device and entrap the UV blocker in the ophthalmic device, wherein the UV blocker is a benzotriazole and (c) sterilizing the de-swelled ophthalmic device.

Abstract: A cassette with free flow prevention for use with an ambulatory pump. The cassette includes a free flow prevention clamp and a housing. The free flow prevention clamp includes a clamping section having a first side and a second side, a first elongate section extending from the first side, and a second elongate section extending from the second side. The housing supports the free flow prevention clamp and defines a channel for receiving a tube. The elongate sections extend parallel to the channel and the clamping section extends across the channel. The free flow prevention clamp is configurable within the housing in an open condition that allows fluid flow through the tube when force is applied to one of the elongate sections and in a closed condition that prevents fluid flow through the tube when the force is removed from the elongate sections.

Abstract: A grafted glycosaminoglycan polymer is disclosed. The grafted glycosaminoglycan polymer comprises a glycosaminoglycan having a polymer backbone and one or more side chains comprising a polyalkylene glycol-containing residue grafted onto the polymer backbone.

Abstract: A glycophospholipid polymer is disclosed. The glycophospholipid polymer comprises a reaction product of one or more glycosaminoglycans and one or more phospholipids. Also disclosed is a glycophospholipid polymeric network comprising a reaction product of one or more glycosaminoglycans, one or more phospholipids and, one or more crosslinking agents.

Abstract: An endoscopic plug for performing an endoscopic procedure includes an external housing and internal tubing for securing within a body cavity opening, the external housing including a plurality of support tabs to secure the external housing to an exterior of the body cavity opening, and the internal tubing including an expandable balloon on an outer surface for expanding within the body cavity to secure the plug within the body cavity. The support tabs, expandable balloon and other features help to create a sealed internal environment for performing water aided endoscopy (“WAE”). The endoscopic plug additionally includes an air passage within the internal tubing to inflate the expandable balloon, sloped edges adjacent to the support tabs to seal the external housing to an external opening of the body cavity, and a plurality of valves, seals and pumps which allow for the introduction and retention of liquid into the body cavity.

Abstract: A method for preparing an ophthalmic device containing an ultraviolet (UV) blocker is disclosed. The method involves (a) soaking an ophthalmic device in one or more first solvent solutions to swell the ophthalmic device; (b) soaking the swelled ophthalmic device in one or more second solvents solutions comprising a UV blocker to de-swell the ophthalmic device and entrap the UV blocker in the ophthalmic device, wherein the UV blocker is a benzotriazole and (c) sterilizing the de-swelled ophthalmic device.